Cargando…
Secondary Lymphoid Organs in Mesenchymal Stromal Cell Therapy: More Than Just a Filter
Mesenchymal stromal cells (MSCs) have demonstrated therapeutic potential in inflammatory models of human disease. However, clinical translation has fallen short of expectations, with many trials failing to meet primary endpoints. Failure to fully understand their mechanisms of action is a key factor...
Autores principales: | Zheng, Di, Bhuvan, Tejasvini, Payne, Natalie L., Heng, Tracy S. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243307/ https://www.ncbi.nlm.nih.gov/pubmed/35784291 http://dx.doi.org/10.3389/fimmu.2022.892443 |
Ejemplares similares
-
Innate lymphoid cells: More than just immune cells
por: Xiong, Le, et al.
Publicado: (2022) -
Lymphoid stromal cells—more than just a highway to humoral immunity
por: Cinti, Isabella, et al.
Publicado: (2021) -
Mesenchymal stromal cell apoptosis is required for their therapeutic function
por: Pang, Swee Heng Milon, et al.
Publicado: (2021) -
Adenosine Deaminase Deficiency – More Than Just an Immunodeficiency
por: Whitmore, Kathryn V., et al.
Publicado: (2016) -
Regulatory dendritic cells: there is more than just immune activation
por: Schmidt, Susanne V., et al.
Publicado: (2012)